Quest Diagnostics Incorporated
DGX
$234.40
-$1.64-0.70%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.04B | 2.90B | 2.81B | 2.82B | 2.76B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.04B | 2.90B | 2.81B | 2.82B | 2.76B |
| Cost of Revenue | 2.02B | 1.95B | 1.89B | 1.87B | 1.82B |
| Gross Profit | 1.03B | 944.00M | 915.00M | 951.00M | 944.00M |
| SG&A Expenses | 526.00M | 498.00M | 486.00M | 491.00M | 480.00M |
| Depreciation & Amortization | 38.00M | 37.00M | 37.00M | 39.00M | 39.00M |
| Other Operating Expenses | -- | -2.00M | 0.00 | 1.00M | -2.00M |
| Total Operating Expenses | 2.58B | 2.48B | 2.41B | 2.40B | 2.33B |
| Operating Income | 464.00M | 411.00M | 392.00M | 420.00M | 427.00M |
| Income Before Tax | 422.00M | 338.00M | 337.00M | 336.00M | 393.00M |
| Income Tax Expenses | 88.00M | 74.00M | 81.00M | 77.00M | 97.00M |
| Earnings from Continuing Operations | 334.00M | 264.00M | 256.00M | 259.00M | 296.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.00M | -12.00M | -11.00M | -14.00M | -14.00M |
| Net Income | 320.00M | 252.00M | 245.00M | 245.00M | 282.00M |
| EBIT | 464.00M | 411.00M | 392.00M | 420.00M | 427.00M |
| EBITDA | 610.00M | 558.00M | 537.00M | 562.00M | 570.00M |
| EPS Basic | 2.87 | 2.28 | 2.21 | 2.17 | 2.51 |
| Normalized Basic EPS | 2.28 | 1.88 | 1.84 | 1.94 | 2.00 |
| EPS Diluted | 2.84 | 2.24 | 2.20 | 2.16 | 2.47 |
| Normalized Diluted EPS | 2.26 | 1.85 | 1.82 | 1.92 | 1.98 |
| Average Basic Shares Outstanding | 111.00M | 110.00M | 111.00M | 112.00M | 112.00M |
| Average Diluted Shares Outstanding | 112.00M | 112.00M | 112.00M | 113.00M | 113.00M |
| Dividend Per Share | 0.86 | 0.86 | 0.80 | 0.80 | 0.80 |
| Payout Ratio | 30.00% | 34.92% | 36.73% | 36.33% | 31.91% |